PE20131106A1 - Aucforma de dosificacion farmaceutica que comprende 6'-fluoro-(n-metil- o n,n-dimetil)-4-fenil-4',9'-dihidro-3'h-espiro[ciclohexan-1,1'-pirano[3,4,b]indol]-4-amina - Google Patents

Aucforma de dosificacion farmaceutica que comprende 6'-fluoro-(n-metil- o n,n-dimetil)-4-fenil-4',9'-dihidro-3'h-espiro[ciclohexan-1,1'-pirano[3,4,b]indol]-4-amina

Info

Publication number
PE20131106A1
PE20131106A1 PE2013000193A PE2013000193A PE20131106A1 PE 20131106 A1 PE20131106 A1 PE 20131106A1 PE 2013000193 A PE2013000193 A PE 2013000193A PE 2013000193 A PE2013000193 A PE 2013000193A PE 20131106 A1 PE20131106 A1 PE 20131106A1
Authority
PE
Peru
Prior art keywords
cyclohexan
indol
dihydro
fluoro
amine
Prior art date
Application number
PE2013000193A
Other languages
English (en)
Inventor
Nadja Gruning
Marc Schiller
Ashish Hemani
Original Assignee
Gruenenthal Chemie
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=43382487&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=PE20131106(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Gruenenthal Chemie filed Critical Gruenenthal Chemie
Publication of PE20131106A1 publication Critical patent/PE20131106A1/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/407—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with other heterocyclic ring systems, e.g. ketorolac, physostigmine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/167—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction with an outer layer or coating comprising drug; with chemically bound drugs or non-active substances on their surface
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2077—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)

Abstract

REFERIDA A UNA FORMA DE DOSIFICACION FARMACEUTICA EN FORMA DE TABLETA QUE CONTIENE UN COMPUESTO DE FORMULA (I), DONDE R ES H O CH3. SON COMPUESTOS FAVORITOS: (1r,4r)-6'-FLUORO-N,N-DIMETIL-4-FENIL-4',9'-DIHIDRO-3'H-ESPIRO[CICLOHEXAN-1,1'-PIRANO[3,4,b]INDOL]-4-AMINA, (1r,4r)-6'-FLUORO-N-METIL-4-FENIL-4',9'-DIHIDRO-3'H-ESPIRO[CICLOHEXAN-1,1'-PIRANO[3,4,b]INDOL]-4-AMINA O UNA SAL DE LOS MISMOS. TAMBIEN CONTIENE UNO O MAS EXCIPIENTES TALES COMO ANTIADHERENTES, AGLUTINANTES, DESINTEGRANTES, MATERIALES DE RELLENO, DILUYENTES, FLUIDIZANTES, LUBRICANTES Y CONSERVADORES. DICHA FORMA DE DOSIFICACION ES UTIL EN EL TRATAMIENTO DEL DOLOR AGUDO, VISCERAL, NEUROPATICO O CRONICO
PE2013000193A 2010-08-04 2011-08-04 Aucforma de dosificacion farmaceutica que comprende 6'-fluoro-(n-metil- o n,n-dimetil)-4-fenil-4',9'-dihidro-3'h-espiro[ciclohexan-1,1'-pirano[3,4,b]indol]-4-amina PE20131106A1 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US37064810P 2010-08-04 2010-08-04
EP10008117 2010-08-04

Publications (1)

Publication Number Publication Date
PE20131106A1 true PE20131106A1 (es) 2013-10-17

Family

ID=43382487

Family Applications (1)

Application Number Title Priority Date Filing Date
PE2013000193A PE20131106A1 (es) 2010-08-04 2011-08-04 Aucforma de dosificacion farmaceutica que comprende 6'-fluoro-(n-metil- o n,n-dimetil)-4-fenil-4',9'-dihidro-3'h-espiro[ciclohexan-1,1'-pirano[3,4,b]indol]-4-amina

Country Status (27)

Country Link
EP (1) EP2600846B1 (es)
JP (1) JP6010534B2 (es)
KR (1) KR101882663B1 (es)
CN (1) CN103079548A (es)
AR (1) AR082561A1 (es)
AU (1) AU2011287952B2 (es)
BR (1) BR112013002696A2 (es)
CA (1) CA2804077C (es)
CL (1) CL2012003583A1 (es)
CO (1) CO6640317A2 (es)
DK (1) DK2600846T3 (es)
EC (1) ECSP13012424A (es)
ES (1) ES2563735T3 (es)
HK (1) HK1183612A1 (es)
HR (1) HRP20151337T1 (es)
HU (1) HUE028436T2 (es)
IL (1) IL223888A (es)
MX (1) MX2013000015A (es)
NZ (1) NZ605841A (es)
PE (1) PE20131106A1 (es)
PL (1) PL2600846T3 (es)
PT (1) PT2600846E (es)
RS (1) RS54659B1 (es)
RU (1) RU2589831C2 (es)
SI (1) SI2600846T1 (es)
TW (1) TWI526445B (es)
WO (1) WO2012016695A2 (es)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HUE039328T2 (hu) 2010-08-04 2018-12-28 Gruenenthal Gmbh 6'-Fluor-(N-metil- vagy N,N-dimetil-)-4-fenil-4',9'-dihidro-3'H-spiro[ciklohexán-1,1'pirano[3,4,B]indol]-4-amin összetételû gyógyszerészeti adagolási forma a neuropátiás fájdalom kezelésére
ES2605786T3 (es) * 2011-12-12 2017-03-16 Grünenthal GmbH Formas sólidas de clorhidrato de (1R,4R)-6'-fluor-N,N-dimetil-4-fenil-4',9'-dihidro-3'H-espiro[ciclohexano-1,1'-pirano[3,4b]indol]-4-amina
SI2797924T1 (sl) * 2011-12-12 2016-08-31 Gruenenthal Gmbh Trdne oblike (1r,4r)-6'-fluoro-N,N-dimetil-4-fenil-4',9'-dihidro-3'H-spiro (ciklo-heksan-1,1'-pirano(3,4,b)indol)-4-amina in žveplove kisline
US20130310435A1 (en) * 2012-05-18 2013-11-21 Gruenenthal Gmbh Pharmaceutical Composition Comprising (1r,4r)-6'-fluoro-N, N-dimethyl-4-phenyl-4,9' -dihydro-3'H-spiro[cyclohexane-1,1' -pyrano[3,4,b]indol]-4-amine and Paracetamol or Propacetamol
US9320729B2 (en) 2012-05-18 2016-04-26 Gruenenthal Gmbh Pharmaceutical composition comprising (1r,4r)-6′-flouro-N,N-dimethyl-4-phenyl-4′,9′-dihydro-3′H-spiro[cyclohexane-1,1′-pyrano-[3,4,b]indol]-4-amine and a propionic acid derivative
US9320725B2 (en) * 2012-05-18 2016-04-26 Gruenenthal Gmbh Pharmaceutical composition comprising (1r,4r)-6′-fluoro-N,N-dimethyl-4-phenyl-4′9′-dihydro-3′H-spiro[cyclohexane-1,1′-pyrano[3,4,b]indol]-4-amine and a gabapentinoid
US20130310385A1 (en) * 2012-05-18 2013-11-21 Gruenenthal Gmbh Pharmaceutical Composition Comprising (1r,4r)-6'-fluoro-N,N-dimethyl-4-phenyl-4',9'-dihydro-3'H-spiro[cyclohexane-1,1'-pyrano[3,4,b]indol]-4-amine and Antidepressants
US9345689B2 (en) * 2012-05-18 2016-05-24 Gruenenthal Gmbh Pharmaceutical composition comprising (1r,4r)-6′-fluoro-N, N-dimethyl-4-phenyl-4,9′-dihydro-3′H-spiro[cyclohexane-1,1′-pyrano[3,4,b]indol]-4-amine and an anticonvulsant
US8912226B2 (en) * 2012-05-18 2014-12-16 Gruenenthal Gmbh Pharmaceutical composition comprising (1r,4r) -6′-fluoro-N,N-dimethyl-4-phenyl-4′,9′-dihydro-3′H-spiro[cyclohexane-1,1′-pyrano[3,4,b]indol]-4-amine and a NSAR
US9308196B2 (en) * 2012-05-18 2016-04-12 Gruenenthal Gmbh Pharmaceutical composition comprising (1 r,4r) -6'-fluoro-N ,N-dimethyl-4-phenyl-4',9'-d ihydro-3'H-spiro[cyclohexane-1,1'-pyrano-[3,4,b]indol]-4-amine and an oxicam
US9855286B2 (en) * 2012-05-18 2018-01-02 Gruenenthal Gmbh Pharmaceutical composition comprising (1r,4r)-6′-fluoro-N,N-di methyl-4-phenyl-4′,9′-dihydro-3′H-spiro[cyclohexane-1,1′-pyrano-[3,4,b]indol]-4-amine and a salicylic acid component
US10034958B2 (en) 2013-06-19 2018-07-31 The Brigham And Women's Hospital, Inc. Nanocomposite hydrogels
TW201642853A (zh) 2015-01-23 2016-12-16 歌林達有限公司 用於治療肝功能之損傷及／或腎功能之損傷個體疼痛之西博帕多（Ｃｅｂｒａｎｏｐａｄｏｌ）
WO2017069822A2 (en) 2015-07-20 2017-04-27 The Brigham And Women's Hospital, Inc. Shear-thinning compositions as an intravascular embolic agent
BR112018017167A2 (pt) 2016-02-29 2019-01-02 Gruenenthal Gmbh titulação de cebranopadol
CN115768772A (zh) * 2020-04-03 2023-03-07 弗特克斯药品有限公司 作为用于治疗α-1抗胰蛋白酶缺乏症(AATD)的α-1抗胰蛋白酶调节剂的吡喃并[4,3-b]L吲哚衍生物
WO2024129782A1 (en) 2022-12-12 2024-06-20 Park Therapeutics, Inc. Regimens and compositions useful for alleviating pain
WO2024173714A1 (en) 2023-02-15 2024-08-22 Park Therapeutics, Inc. Regimens and compositions useful for alleviating pain

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6294192B1 (en) * 1999-02-26 2001-09-25 Lipocine, Inc. Triglyceride-free compositions and methods for improved delivery of hydrophobic therapeutic agents
DE10252667A1 (de) * 2002-11-11 2004-05-27 Grünenthal GmbH Spirocyclische Cyclohexan-Derivate
DE102005005446A1 (de) * 2005-02-04 2006-08-10 Grünenthal GmbH Bruchfeste Darreichungsformen mit retardierter Freisetzung
DE102006046745A1 (de) * 2006-09-29 2008-04-03 Grünenthal GmbH Gemischte ORL1/µ-Agonisten zur Behandlung von Schmerz

Also Published As

Publication number Publication date
ES2563735T3 (es) 2016-03-16
TW201219399A (en) 2012-05-16
KR101882663B1 (ko) 2018-07-30
KR20130097172A (ko) 2013-09-02
HUE028436T2 (hu) 2016-12-28
CO6640317A2 (es) 2013-03-22
JP6010534B2 (ja) 2016-10-19
WO2012016695A3 (en) 2012-08-16
PL2600846T3 (pl) 2016-05-31
RU2013109138A (ru) 2014-09-10
NZ605841A (en) 2014-07-25
CN103079548A (zh) 2013-05-01
AU2011287952B2 (en) 2014-08-21
CL2012003583A1 (es) 2013-02-01
CA2804077C (en) 2018-09-11
AU2011287952A1 (en) 2013-03-21
WO2012016695A2 (en) 2012-02-09
HK1183612A1 (en) 2014-01-03
SI2600846T1 (sl) 2016-02-29
EP2600846A2 (en) 2013-06-12
PT2600846E (pt) 2016-02-09
BR112013002696A2 (pt) 2016-05-31
CA2804077A1 (en) 2012-02-09
MX2013000015A (es) 2013-02-01
AR082561A1 (es) 2012-12-19
RU2589831C2 (ru) 2016-07-10
IL223888A (en) 2017-01-31
HRP20151337T1 (hr) 2016-01-01
EP2600846B1 (en) 2015-11-25
DK2600846T3 (en) 2016-01-11
RS54659B1 (en) 2016-08-31
ECSP13012424A (es) 2013-03-28
JP2013532695A (ja) 2013-08-19
TWI526445B (zh) 2016-03-21

Similar Documents

Publication Publication Date Title
PE20131106A1 (es) Aucforma de dosificacion farmaceutica que comprende 6'-fluoro-(n-metil- o n,n-dimetil)-4-fenil-4',9'-dihidro-3'h-espiro[ciclohexan-1,1'-pirano[3,4,b]indol]-4-amina
PE20131096A1 (es) Forma de dosificacion farmaceutica que comprende 6'-fluoro-(n-metil-o n,n-dimetil)-4-fenil-4',9-dihidro-3'h-espiro[ciclohxan-1,1'-pirano[3,4,b]indol]-4-amina para el tratamiento de dolor neuropatico
ECSP22091792A (es) Compuestos tricíclicos sustituidos como inhibidores del receptor del factor de crecimiento de fibroplastos
CO7400871A2 (es) Compuestos de piridilo sustituidos con heteroarilo útiles como moduladores de cinasa
AR090456A1 (es) Combinaciones farmaceuticas que comprenden un analogo de tionucleotidos
PE20150886A1 (es) Compuestos de benceno sustituidos
EA201270597A1 (ru) Соединения, модулирующие андрогеновые рецепторы
UY35143A (es) Derivados de dihidropirazol como moduladores del receptor acoplado a la proteína gpr40 g
PL2600838T3 (pl) Farmaceutyczna postać dawkowania zawierająca 6'-fluoro-(N-metylo- lub N,N-dimetylo)-4-fenylo-4'9'-dihydro-3'H-spiro[cykloheksano-1,1'-pirano[3,4b]indolo]-4-aminę
PH12018500377A1 (en) Novel annelated benzamides
CL2012000263A1 (es) Compuestos derivados de amidas espiro ciclica, agonista b-adrenoreceptor y antagonista muscarinico; utiles en el tratamiento en enfermedades inflamatorias, tales como epoc.
SA518390920B1 (ar) مركبات فينوكسي أسيتاميد معالجة بإضافة حلقة
UY33509A (es) Metodos y composiciones para el tratamiento de la alergia
MX364400B (es) Compuestos de tetraciclina.
EA201400120A1 (ru) Кристаллический (1r,4r)-6'-фтор-n,n-диметил-4-фенил-4',9'-дигидро-3'н-спиро[циклогексан-1,1'-пирано[3,4,в]индол]-4-амин
ZA201300038B (en) Pharmaceutical dosage form comprising 6'-fluoro-(n-methyl-or n,n-dimethyl-)-4-phenyl-4,9'-dihydro-3'h-spiro[cyclohexane-1,1'-pyrano[3,4,b]indol]-4-amine
HRP20171843T1 (hr) Farmaceutski pripravak koji sadrži (1r,4r)-6'-fluoro-n,n-dimetil-4-fenil-4',9'-dihidro-3'h-spiro[cikloheksan-1,1'-pirano [3,4,b]indol]-4-amin i meloksikam
EA201401269A1 (ru) Фармацевтическая композиция, содержащая (1r,4r)-6'-фтор-n,n-диметил-4-фенил-4',9'-дигидро-3'h-спиро[циклогексан-1,1'-пирано[3,4,b]индол]-4-амин и антидепрессанты
EA201401272A1 (ru) Фармацевтическая композиция, содержащая (1r,4r)-6'-фтор-n,n-диметил-4-фенил-4',9'-дигидро-3'h-спиро[циклогексан-1,1'-пирано-[3,4,b]индол]-4-амин и парацетамол или пропацетамол
CY1120616T1 (el) Φαρμακευτικη μορφη δοσολογιας η οποια περιλαμβανει 6'-φθορο-(ν-μεθυλ- ή ν,ν-διμεθυλ-)-4-φαινυλ-4',9'-διυδρο-3'η-σπειρο[κυκλοεξανο-1,1'-πυρανο[3,4,β]ινδολ]-4-αμινη για την αγωγη του νευροπαθητικου πονου
ECSP15001225A (es) Compuestos tricíclicos sustituidos como inhibidores del receptor del factor de crecimiento de fibroblastos
CR20140577A (es) Compuestos triciclicos sustituidos como inhibidores del receptor del factor de crecimiento de fibroblastos (fgfr)
EA201591023A1 (ru) Твердая форма производного дигидропиридооксазина
NZ728036A (en) Pharmaceutical compositions comprising antibacterial agents
IN2013MU03656A (es)

Legal Events

Date Code Title Description
FG Grant, registration